More specifically, we hypothesize that the patient population, including those pursuing pharmacological assistance to aid their weight loss journey, may disproportionately represent the more motivated patients
ACE inhibitors, ARBs, and potassium-sparing diuretics can increase potassium levels, while loop and thiazide diuretics can decrease potassium levels
The entire reason that Medicare doesnt cover obesity treatment is that historically, weight loss drugs that proved effective at reducing body mass also caused serious issues In the 1990s, Fen-phen was withdrawn after causing heart valve damage
IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine
Shima Hadidchi, MD , as the medication works best in combination with dietary changes and physical activity
The integration of these therapies represents a paradigm shift in diabetes care, expanding treatment options for people with diabetes mellitus at risk of kidney failure